目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to mRNA Vaccines & Therapeutics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Diverse Applications of mRNA Post COVID-19 Vaccine Success
3.2.1.2 Significant Research Funding to Boost Market Growth
3.2.1.3 Technological Advances Driving the Market Growth
3.2.2 Market Restraining Factors
3.2.2.1 Scalability and Cost-Effectiveness is Still a Major Bottleneck
3.2.3 Market Opportunities
3.2.3.1 mRNA Cancer Vaccines
3.2.3.2 Analytics, Machine Learning and Cloud Data Warehousing
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors
3.5.2 Economic Factors
3.5.3 Social Factors
3.5.4 Technological Factors

4 Global mRNA vaccines & therapeutics Market, By Type
4.1 Key Findings
4.2 Type Segment Growth Prospects
4.3 Global mRNA vaccines & therapeutics Market Size Estimation and Forecast by Type
4.4 Prophylactic vaccines
4.4.1 Market Size by Region, 2022-2032 (US$ Mn)
4.4.2 Market Share by Region, 2022-2032 (%)
4.5 Therapeutic Vaccines Market
4.5.1 Therapeutics Vaccines Market Forecast by Region, 2022-2032 (US$ Mn)
4.5.2 Therapeutic Vaccine Forecast by Region, 2022-2032 (%)
4.6 mRNA Therapeutics Market Forecast
4.6.1 mRNA Therapeutics Market Forecast by Region 2022-2032 (US$ Mn)
4.6.2 mRNA Therapeutics Market by Region, 2022-2032 (%)

5 mRNA Vaccines & Therapeutics Market Analysis by Applications
5.1 Key Findings
5.2 Applications Segment Growth Prospects
5.3 Global mRNA vaccines & therapeutics Market Size Estimation and Forecast by Applications
5.4 mRNA vaccines & therapeutics Market Share by Applications, 2022 & 2032
5.5 Cell Therapy
5.5.1 Cell Therapy Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 Cell Therapy Market Share by Region, 2022-2032 (%)
5.6 Gene Editing
5.6.1 Gene Editing Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 Gene Editing Market Share by Region, 2022-2032 (%)
5.7 Protein Replacement Therapy
5.7.1 Protein Replacement Market Forecast by Region, 2022-2032 (US$ Mn)
5.7.2 Protein Replacement Market Share by Region, 2022-2032 (%)
5.8 Cancer Immunotherapy
5.8.1 Cancer Immunotherapy Market Forecast by Region, 2022-2032 (US$ Mn)
5.8.2 Cancer Immunotherapy Market Share by Region, 2022-2032 (%)
5.9 Infectious Diseases
5.9.1 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Mn)
5.9.2 mRNA Infectious Diseases Application Market Share by Region, 2022-2032 (%)

6 mRNA Vaccine & Therapeutics Market, By Vector Platform
6.1 Key Findings
6.2 Vector Platform Segment Growth Prospects
6.3 Global mRNA vaccines & therapeutics Market Size Estimation and Forecast by Vector Platform
6.4 Global mRNA vaccines & therapeutics Market Share by Vector Platforms, 2022 & 2032
6.5 Self-Amplifying mRNA
6.5.1 Self-Amplifying mRNA Market Forecast by Region, 2022-2032 (US$ Mn)
6.5.2 Self-Amplifying mRNA Market Share by Region, 2022-2032 (%)
6.6 Non-Amplifying (Conventional) mRNA
6.6.1 Non-Amplifying mRNA Market Forecast by Region, 2022-2032 (US$ Mn)
6.6.2 Non-Amplifying mRNA Market Share by Region, 2022-2032 (%)

7 Global mRNA Vaccines & Therapeutics Market, By Delivery Mode
7.1 Key Findings
7.2 Delivery Platform Segment Growth Prospects
7.3 Global mRNA Vaccines & Therapeutics Market Size Estimation and Forecast, by Delivery Platform, 2022 & 2032
7.4 Naked mRNA Delivery
7.4.1 Naked Delivery Platform Forecast by Region, 2022-2032 (US$ Mn)
7.4.2 Naked Delivery Platform Market Share by Region, 2022-2032 (%)
7.5 Cell-Specific Delivery Platform
7.5.1 Cell Specific Delivery Platform by Region, 2022-2032 (US$ Mn)
7.5.2 Cell Specific Delivery Platform Market Share by Region, 2022-2032 (%)
7.6 Carrier Mediated
7.6.1 Carrier Mediated Delivery Platform Market by Region, 2022-2032 (US$ Mn)
7.6.2 Carrier Mediated Platform Market Share by Region, 2022-2032 (%)
7.6.3 Carrier Mediated Delivery Platform Market by Types, 2022-2032 (US$ Mn)
7.6.3.1 Viral Vector
7.6.3.1.1.1 Viral Vector Market by Region, 2022-2032 (US$ Mn)
7.6.3.1.1.2 Viral Vector Market Share by Region, 2022-2032 (%)
7.6.3.2 Non-Viral
7.6.3.2.1 Non-Viral Market by Region, 2022-2032 (US$ Mn)
7.6.3.2.2 Non-Viral Market Share by Region, 2022-2032 (%)
7.6.3.3 Non-Viral Vector Market by Types, 2022-2032 (US$ Mn)
7.6.3.3.1.1 Lipid Nanoparticles (LNP)
7.6.3.3.1.2 Peptide-based Vectors
7.6.3.3.1.3 Polymer-based Vectors

8 Global mRNA Vaccines & Therapeutics Market, By Route of Delivery
8.1 Key Findings
8.2 Route of Delivery Segment Growth Prospects
8.3 Global mRNA vaccines & therapeutics Market Size Estimation and Forecast, by Route of Delivery, 2022 & 2032
8.4 Intradermal
8.4.1 Intradermal Route of Delivery Forecast by Region, 2022-2032 (US$ Mn)
8.4.2 Intradermal Route of Delivery Forecast by Region, 2022-2032 (%)
8.5 Subcutaneous
8.5.1 Subcutaneous Route of Delivery Forecast by Region, 2022-2032 (US$ Mn)
8.5.2 Subcutaneous Route of Delivery Forecast by Region, 2022-2032 (%)
8.6 Intramuscular
8.6.1 Intramuscular Route of Delivery Forecast by Region, 2022-2032 (US$ Mn)
8.6.2 Intramuscular Route of Delivery Forecast by Region, 2022-2032 (%)
8.7 Intravenous
8.7.1 Intravenous Route of Delivery Forecast by Region, 2022-2032 (US$ Mn)
8.7.2 Intravenous Route of Delivery Forecast by Region, 2022-2032 (%)
8.8 Intranodal
8.8.1 Intranodal Route of Delivery Forecast by Region, 2022-2032 (US$ Mn)
8.8.2 mRNA Intranodal Route of Delivery Forecast by Region, 2022-2032 (%)

9 Global mRNA Based Therapeutics and Vaccine Market by End-User
9.1 Key Findings
9.2 End Users Segment Growth Prospects
9.3 Global mRNA vaccines & therapeutics Market Size Estimation, by End Users, 2022 & 2032
9.4 Research Organizations
9.4.1 Research Organizations Market Forecast, By End Users, by Region, 2022-2032 (US$ Mn)
9.4.2 Research Organizations Market Share by Region, 2022-2032 (%)
9.5 Hospitals & Clinics Segment Market Forecast, 2022-2032
9.5.1 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ Mn)
9.5.2 Hospitals & Clinics Market Forecast, by Region, 2022-2032 (%)`

10 Global mRNA vaccines & therapeutics Market Analysis by Region
10.1 Key Findings
10.2 Regional Market Size Estimation and Forecast
10.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

11 North America mRNA Vaccines & Therapeutics Market Analysis
11.1 Key Findings
11.2 North America mRNA Vaccines & Therapeutics Market Attractiveness Index
11.3 North America mRNA Vaccines & Therapeutics Market by Country, 2022, 2027 & 2032 (US$ mn)
11.4 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Country
11.5 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Types
11.6 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Platform
11.7 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Delivery Platform
11.7.1 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Carrier Mediated Vector Delivery Platform
11.7.1.1 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Non-Viral Vector Delivery Platform
11.8 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Applications
11.9 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Route of Delivery
11.10 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast, by End-Users
11.11 North America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast, by Country
11.11.1 U.S.
11.11.2 Canada

12 Europe mRNA Vaccines & Therapeutics Market Analysis
12.1 Key Findings
12.2 Europe mRNA Vaccines & Therapeutics Market Attractiveness Index
12.3 Europe mRNA Vaccines & Therapeutics Market by Country, 2022, 2027 & 2032 (US$ mn)
12.4 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Country
12.5 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Types
12.6 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Platform
12.7 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Delivery Platform
12.7.1 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Carrier Vector Delivery Platform
12.7.1.1 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Non-Viral Vector Delivery Platform
12.8 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Applications
12.9 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Route of Delivery
12.10 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast, by End-Users
12.11 Europe mRNA Vaccines & Therapeutics Market Size Estimation and Forecast, by Country
12.11.1 Germany
12.11.2 U.K.
12.11.3 France
12.11.4 Spain
12.11.5 Italy
12.11.6 Rest of Europe

13 Asia Pacific mRNA Vaccines & Therapeutics Market Analysis
13.1 Key Findings
13.2 Asia Pacific mRNA Vaccines & Therapeutics Market Attractiveness Index
13.3 Asia Pacific mRNA Vaccines & Therapeutics Market by Country, 2022, 2027 & 2032 (US$ Mn)
13.4 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Country
13.5 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Types
13.6 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Platform
13.7 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Delivery Platform
13.7.1 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Carrier Mediated Vector Delivery Platform
13.7.1.1 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Carrier Mediated Non-Viral Vector Delivery Platform
13.8 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Applications
13.9 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Route of Delivery
13.10 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast, by End-Users
13.11 Asia Pacific mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Country
13.11.1 China
13.11.2 India
13.11.3 Japan
13.11.4 South Korea
13.11.5 Australia
13.11.6 Rest of Asia Pacific

14 Latin America mRNA Vaccines & Therapeutics Market Analysis
14.1 Key Findings
14.2 Latin America mRNA Vaccines & Therapeutics Market Attractiveness Index
14.3 Latin America mRNA Vaccines & Therapeutics Market by Country, 2022, 2027 & 2032 (US$ Mn)
14.4 Latin America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Country
14.5 Latin America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Types
14.6 Latin America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Platform
14.7 Latin America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Delivery Platform
14.7.1 Latin America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Carrier Mediated Vector Delivery Platform
14.7.1.1 Latin America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Carrier Mediated Non-Viral Vector Delivery Platform
14.8 Latin America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Applications
14.9 Latin America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Route of Delivery
14.10 Latin America mRNA Vaccines & Therapeutics Market Size Estimation and Forecast, by End-Users
14.10.1 Brazil
14.10.2 Argentina
14.10.3 Mexico
14.10.4 Rest of Latin America

15 Middle East & Africa mRNA Vaccine & Therapeutics Market Analysis
15.1 Key Findings
15.2 Middle East & Africa mRNA Vaccines & Therapeutics Market Attractiveness Index
15.3 Middle East & Africa mRNA Vaccines & Therapeutics Market by Country, 2022, 2027 & 2032 (US$ Mn)
15.4 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Country
15.5 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Types
15.6 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Platform
15.7 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Vector Delivery Platform
15.7.1 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Carrier Mediated Vector Delivery Platform
15.7.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Carrier Mediated Non-Viral Vector Delivery Platform
15.8 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Applications
15.9 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Estimation and Forecast by Route of Delivery
15.10 Middle East & Africa mRNA vaccines & therapeutics Market Size Estimation and Forecast, by End-Users
15.10.1 Saudi Arabia
15.10.2 UAE
15.10.3 Turkey
15.10.4 South Africa
15.10.5 Rest of Middle East & Africa

16 Company Profiles
16.1 Company Share Analysis
16.2 Key Business Strategy Analysis
16.3 AstraZeneca PLC
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.3.1 Net Revenue, 2017-2021
16.3.3.2 Core Operating Profit, 2017-2021
16.3.3.3 R&D, 2017-2021
16.3.3.4 Regional Pharmaceutical Market Revenue, 2017-2021
16.3.4 AstraZeneca: COVID Vaccine Sales, 2021
16.3.5 AstraZeneca PLC: Development Pipeline
16.3.6 Strategic Outlook
16.4 Moderna
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.3.1 Net Revenue, 2017-2021
16.4.3.2 R&D Expense, 2017-2021
16.4.3.3 Regional Pharmaceutical Market Shares, 2021
16.4.4 Moderna: Vaccines & Therapeutics Development Pipeline
16.4.5 Strategic Outlook
16.5 CureVac N.V.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.3.1 Net Revenue, 2018-2021
16.5.3.2 CureVac N.V. Revenues from Contract Customers: 2018-2021
16.5.3.3 R&D Expense, 2018-2021
16.5.3.4 Regional Pharmaceutical Market Shares (%), 2018-2021
16.5.4 CureVac N.V.: Vaccines & Therapeutics Development Pipeline
16.5.5 Strategic Outlook
16.6 BioNTech SE
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.3.1 Net Revenue, 2018-2021
16.6.3.2 BioNTech SE Revenues from R&D Collaborations: 2018-2021
16.6.3.3 R&D Expense, 2018-2021
16.6.3.4 Regional Revenues by Collaborations (US$ Million), 2018-2021
16.6.4 BioNTech SE: Vaccines & Therapeutics Development Pipeline
16.6.5 Strategic Outlook
16.7 Pfizer Inc.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.3.1 Net Revenue, 2017-2021
16.7.3.2 Net Income: 2017-2021
16.7.4 Pfizer Inc.: mRNA Vaccine Approval Status
16.7.5 Strategic Outlook
16.8 GSK Plc.
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.3.1 Net Revenue, 2017-2021
16.8.3.2 R&D Expense: 2017-2021
16.8.3.3 Geographic Revenues, By Segment, 2019-2021
16.8.3.4 Regional Revenues (US$ Million), 2018-2021
16.8.4 GSK Inc.: mRNA Vaccine Pipeline Status
16.8.5 Strategic Outlook
16.9 Arcturus Therapeutics Holdings Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.3.1 Net Revenue, 2019-2021
16.9.3.2 Arcturus Therapeutics Holdings Inc., Collaboration Revenues (2019-2021)
16.9.4 Arcturus Therapeutics Holdings Inc: mRNA Vaccine Pipeline Status
16.9.5 Strategic Outlook
16.10 Translate Bio ( now A Sanofi Company)
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.3.1 Net Revenue, 2018-2020
16.10.3.2 R&D Expense (US$ Million), 2018-2020
16.10.4 Translate Bio (a Sanofi Company): mRNA Vaccine Pipeline Status
16.10.5 Strategic Outlook
16.11 Sanofi
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.3.1 Net Revenue, 2017-2021
16.11.3.2 R&D Expense (US$ Million), 2017-2021
16.11.3.3 Sanofi, Net Income (2017-2021)
16.11.4 Sanofi Company: mRNA Vaccine Pipeline Status
16.11.5 Strategic Outlook
16.12 eTheRNA
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Partnerships/ Strategic Collaborations
16.12.4 Strategic Outlook
16.13 Stemirna Therapeutics
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Stemirna: mRNA Vaccine Pipeline Status
16.14 Cartesian Therapeutics
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Cartesian: mRNA Vaccine Pipeline Status
16.14.4 Strategic Outlook
16.15 Ethris
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Ethris: mRNA Vaccine Pipeline Status
16.15.4 Strategic Outlook

17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players
?

List of Tables
Table 1 Global mRNA Vaccines & Therapeutics Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Global mRNA vaccines & therapeutics market : Phase III
Table 3 Global mRNA vaccines & therapeutics market : Companies & Delivery Platforms
Table 4 Global mRNA vaccines & therapeutics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 5 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 6 Global mRNA vaccines & Therapeutic Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 7 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 8 Global mRNA vaccines & therapeutics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 9 Prophylactic Vaccine in Pipeline Analysis
Table 10 Prophylactic vaccines Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 11 mRNA Cancer Vaccine in Pipeline Analysis
Table 12 Therapeutic Vaccine Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 13 mRNA Cancer Vaccine in Pipeline Analysis
Table 14 mRNA Therapeutics Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 15 Global mRNA vaccines & therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%, CAGR %)
Table 16 Cell Therapy Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 17 mRNA vaccines & Therapeutics, Gene Editing Market By Application Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 18 Clinical Trials of mRNA for Protein-Replacement Therapies
Table 19 mRNA vaccines & Therapeutics, Protein Replacement Market By Application Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 20 Clinical Trials of mRNA for Cancer vaccines and Therapeutic
Table 21 mRNA vaccines & Therapeutics, Cancer Immunotherapy Market By Application Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 22 Clinical Trials of mRNA for Infectious Diseases
Table 23 mRNA vaccines & Therapeutics, Infectious Diseases Market By Application Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 24 Global mRNA vaccines & therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 25 Self-Amplifying mRNA Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 26 Non-Amplifying mRNA Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 27 Global mRNA vaccines & therapeutics Market Forecast by Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 28 Naked Delivery Platform Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 29 mRNA Therapeutic & Vaccine Forecast by Cell Specific Delivery
Table 30 Cell Specific Delivery Platform Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 31 Carrier Mediated Delivery Platform Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 32 Carrier Mediated Delivery Platform Market Forecast by Types, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 33 Viral Vector Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 34 Non- Viral Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 35 Non-Viral Vector Market Forecast by Types, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 36 mRNA delivery by Lipid Nanoparticle Platform Clinical trials
Table 37 Lipid Nano Particles Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 38 Global Peptide-based Vectors Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 39 Global Polymer-based Vectors Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 40 Global mRNA Therapeutic and Vaccine Delivery, By Route of Administration Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 41 Global mRNA vaccines & therapeutics Market Forecast by Route of Delivery, 2022-2032 (US$ million, AGR%, CAGR %)
Table 42 Intradermal Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 43 Subcutaneous Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 44 Intramuscular Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 45 Intravenous Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 46 Intranodal Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 47 Global mRNA vaccines & therapeutics Market Forecast by End Users, 2022-2032 (US$ million, AGR%, CAGR %)
Table 48 Research Organizations Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 49 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Table 50 Global mRNA Vaccines & Therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 51 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 52 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 53 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 54 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 55 North America mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 56 North America mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR%, CAGR %)
Table 57 North America mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 58 North America mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 59 North America mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 60 North America mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 61 North America mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%, CAGR %)
Table 62 North America mRNA vaccines & therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR%, CAGR%)
Table 63 North America mRNA vaccines & therapeutics market Forecast By End Users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 64 U.S. mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 65 Canada mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 66 Europe mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 67 .Europe mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR%, CAGR %)
Table 68 Europe mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 69 Europe mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 70 Europe mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 71 Europe mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 72 Europe mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%, CAGR%)
Table 73 Europe mRNA vaccines & therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR%, CAGR%)
Table 74 Europe mRNA vaccines & therapeutics market Forecast By End Users, 2022-2032 (US$ million, AGR%, CAGR %)
Table 75 Germany mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
Table 76 UK mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 77 France mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 78 Spain mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
Table 79 Italy mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 80 Rest of Europe mRNA Vaccines & Therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 81 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 82 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR%, CAGR %)
Table 83 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 84 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 85 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 86 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 87 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%, CAGR %)
Table 88 Asia Pacific mRNA vaccines & therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR%, CAGR%)
Table 89 Asia Pacific mRNA vaccines & therapeutics market Forecast By End Users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 90 China mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 91 India mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 92 Japan mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 93 South Korea mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 94 Australia mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 95 ROA mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 96 Latin America mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 97 Latin America mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR%, CAGR %)
Table 98 Latin America mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 99 Latin America mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 100 .Latin America mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 101 Latin America mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 102 Latin America mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%, CAGR%)
Table 103 Latin America mRNA vaccines & therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR%, CAGR%)
Table 104 Latin America mRNA Vaccines & Therapeutics market Forecast by End Users-2032 (US$ million, AGR%, CAGR %)
Table 105 Brazil mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 106 Argentina mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
Table 107 Mexico mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
Table 108 Rest of Latin America mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
Table 109 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 110 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR%, CAGR %)
Table 111 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 112 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 113 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR%)
Table 114 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR%, CAGR %)
Table 115 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR%, CAGR%)
Table 116 Middle East & Africa mRNA vaccines & therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR%, CAGR%)
Table 117 Middle East & Africa mRNA vaccines & therapeutics Market Forecast By End Users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 118 Saudi Arabia mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 119 UAE mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 120 Turkey mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 121 South Africa mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 122 Rest of Middle East mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 123 Key Business Strategies Adopted by Key Players in Global MRNA vaccines & therapeutics market
Table 124 AstraZeneca PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 AstraZeneca PLC: Pipeline Development
Table 126 AstraZeneca PLC : Strategic Outlook
Table 127 Moderna: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Moderna : mRNA Therapeutics & vaccines Pipeline 2022-2032
Table 129 Moderna : Strategic Outlook
Table 130 CureVac N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 CureVac N.V., Revenues from Contract Customers,2018-2021 (US$ million, AGR %)
Table 132 CureVac N.V.: mRNA Therapeutics & Vaccines Pipeline 2022-2032
Table 133 CureVac N.V.: Strategic Outlook
Table 134 BioNTech SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 BioNTech SE, Revenues from R&D Collaborations,2018-2021 (US$ million)
Table 136 BioNTech SE: mRNA Therapeutics & Vaccines Pipeline 2022-2032
Table 137 BioNTech SE: Strategic Outlook
Table 138 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Pfizer Inc.: mRNA Vaccine Approval Status
Table 140 Pfizer Inc.: Strategic Outlook
Table 141 GSK Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 GSK Plc: Revenues, By Segment, 2019-2021 (US$ million, AGR %)
Table 143 GSK Plc: Regional Revenues, 2018-2021 (US$ million)
Table 144 GSK Plc: mRNA Vaccine Approval Status
Table 145 GSK Plc: Strategic Outlook
Table 146 Arcturus Therapeutics Holdings Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 Arcturus Therapeutics Holdings Inc.: mRNA Vaccine and Therapeutics Pipeline
Table 148 Arcturus Therapeutics Holdings Inc.: Strategic Outlook
Table 149 Translate Bio ( A Sanofi Company).: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 Translate Bio ( A Sanofi Company).: mRNA Vaccine and Therapeutics Pipeline
Table 151 Translate Bio ( A Sanofi Company).: Strategic Outlook
Table 152 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 153 Sanofi: mRNA Vaccine and Therapeutics Pipeline
Table 154 Sanofi: Strategic Outlook
Table 155 eTheRNA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 ETheRNA: mRNA Strategic Collaborations
Table 157 ETheRNA: Strategic Outlook
Table 158 Stemirna Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 159 Stemirna Therapeutics: mRNA Strategic Collaborations
Table 160 Cartesian Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 161 Cartesian Therapeutics: mRNA Strategic Collaborations
Table 162 Cartesian : Strategic Outlook
Table 163 Ethris: mRNA Pipeline
Table 164 Ethris: Strategic Outlook
?

List of Figures
Figure 1 Global mRNA Vaccines & Therapeutics Market Segmentation
Figure 2 Global mRNA vaccines & therapeutics Market Forecast by Region: Market Attractiveness Index
Figure 3 Global mRNA vaccines & therapeutics Market by Therapeutics: Market Attractiveness Index
Figure 4 Global mRNA vaccines & therapeutics Market by Vector Platform: Market Attractiveness Index
Figure 5 Global mRNA vaccines & therapeutics Market by Delivery Platform: Market Attractiveness Index
Figure 6 Global mRNA vaccines & therapeutics Market by Route of Administration: Market Attractiveness Index
Figure 7 Global mRNA vaccines & therapeutics Market by Applications: Market Attractiveness Index
Figure 8 Global mRNA vaccines & therapeutics market by End Users : Market Attractiveness Index
Figure 9 Global mRNA vaccines & therapeutics market Dynamics
Figure 10 Global COVID Impact Analysis: mRNA vaccines & therapeutics Market Recovery Scenarios (US$ million, CAGR %)
Figure 11 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 12 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 13 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 14 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 15 Global mRNA vaccines & therapeutics Market: Porter’s Five Forces Analysis
Figure 16 Global mRNA vaccines & therapeutics Market: PEST Analysis
Figure 17 Global mRNA Vaccines & Therapeutics Market: Growth Prospects by Type
Figure 18 Global mRNA vaccines & therapeutics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 19 Global mRNA vaccines & therapeutics Market Share Forecast by Type, 2022, 2032 (%)
Figure 20 Prophylactic vaccines Market Forecast by Region, 2022-2032 (US$ Mn)
Figure 21 Prophylactic vaccines Market Forecast by Region, 2022-2032 (%)
Figure 22 Therapeutic Vaccine Forecast by Region, 2022-2032 (US$ million)
Figure 23 Therapeutic Vaccine Forecast by Region, 2022-2032 (%)
Figure 24 mRNA Therapeutics Market Forecast by Region, 2022-2032 (US$ million)
Figure 25 mRNA Therapeutics Market Forecast by Region, 2022-2032 (%)
Figure 26 Global mRNA Vaccines & Therapeutics Market: Growth Prospects by Applications
Figure 27 Global mRNA vaccines & therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %)
Figure 28 mRNA vaccines & therapeutics Market Share Forecast by Applications, 2022, 2032 (%)
Figure 29 Cell Therapy Market Forecast by Region, 2022-2032 (US$ million)
Figure 30 Cell Therapy Market Share by Region, 2022-2032 (%)
Figure 31 mRNA Vaccine & Therapeutics, By Gene Editing Forecast by Region, 2022-2032 (US$ million)
Figure 32 mRNA Gene Editing Application Market, Forecast by Region, 2022-2032 (%)
Figure 33 mRNA Vaccine & Therapeutics, By Protein Replacement Forecast by Region, 2022-2032 (US$ million)
Figure 34 mRNA Protein Replacement Application Market, Forecast by Region, 2022-2032 (%)
Figure 35 mRNA Vaccine & Therapeutics, By Cancer Immunotherapy Forecast by Region, 2022-2032 (US$ million)
Figure 36 mRNA Cancer Immunotherapy Application Market, Forecast by Region, 2022-2032 (%)
Figure 37 mRNA Vaccine & Therapeutics, By Infectious Diseases Forecast by Region, 2022-2032 (US$ million)
Figure 38 mRNA Infectious Diseases Application Market, Forecast by Region, 2022-2032 (%)
Figure 39 Global mRNA Vaccines & Therapeutics Market: Growth Prospects by Vector Platform
Figure 40 Global mRNA vaccines & therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR %)
Figure 41 Global mRNA vaccines & therapeutics Market Share Forecast by Vector Platform, 2022, 2032 (%)
Figure 42 Self-Amplifying mRNA Forecast by Region, 2022-2032 (US$ million)
Figure 43 Self-Amplifying mRNA Market, Forecast by Region, 2022-2032 (%)
Figure 44 Non-Amplifying mRNA Forecast by Region, 2022-2032 (US$ million)
Figure 45 Non-Amplifying mRNA Market, Forecast by Region, 2022-2032 (%)
Figure 46 Global mRNA Vaccines & Therapeutics Market: Growth Prospects by Delivery Platform
Figure 47 Global mRNA vaccines & therapeutics Market Forecast by Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 48 Global mRNA vaccines & therapeutics Market Share Forecast by Delivery Platform, 2022, 2032 (%)
Figure 49 Naked Delivery Platform Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Figure 50 Naked Delivery Platform Market Forecast by Region, 2022-2032(%)
Figure 51 Cell Specific Delivery Platform Market Forecast by Region, 2022-2032 (US$ million)
Figure 52 Cell Specific Delivery Platform Market Forecast by Region, 2022-2032 (US$ million), 2022-2032 (%)
Figure 53 Carrier Mediated Platform Market Forecast by Region, 2022-2032 (US$ million)
Figure 54 Carrier Mediated Delivery Platform Market Forecast by Region, 2022-2032 (US$ million), 2022-2032 (%)
Figure 55 Viral Vector Market Forecast by Region, 2022-2032 (US$ million)
Figure 56 Viral Vector Market Share Forecast by Region, 2022-2032 (US$ million), 2022-2032 (%)
Figure 57 Non-Viral Market Forecast by Region, 2022-2032 (US$ million)
Figure 58 Non-Viral Market Forecast by Region, 2022-2032 (US$ million), 2022-2032 (%)
Figure 59 Lipid Nano-Particles Market Forecast by Region, 2022-2032 (US$ million)
Figure 60 Lipid Nano-Particles Market Forecast by Region, 2022-2032 (US$ million), 2022-2032 (%)
Figure 61 Peptide-based Vectors Market Forecast by Region, 2022-2032 (US$ million)
Figure 62 Peptide-based Vectors Market Forecast by Region, 2022-2032 (US$ million), 2022-2032 (%)
Figure 63 Polymer-based Vectors Market Forecast by Region, 2022-2032 (US$ million)
Figure 64 Polymer-based Vectors Market Forecast by Region, 2022-2032 (US$ million), 2022-2032 (%)
Figure 65 Global mRNA Vaccines & Therapeutics Market Forecast by Route of Administration 2022, 2027, 2032 (Revenue, CAGR %)
Figure 66 Global mRNA vaccines & therapeutics Market Forecast by Route of Delivery, 2022-2032 (US$ million, AGR %)
Figure 67 Global mRNA vaccines & therapeutics Market Share Forecast by Route of Delivery, 2022, 2032 (%)
Figure 68 Intradermal Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Figure 69 Intradermal Route of Delivery Market Forecast by Region, 2022-2032(%)
Figure 70 Subcutaneous Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Figure 71 Subcutaneous Route of Delivery Market Forecast by Region, 2022-2032(%)
Figure 72 Intramuscular Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Figure 73 Intramuscular Route of Delivery Market Forecast by Region, 2022-2032(%)
Figure 74 Intravenous Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Figure 75 Intravenous Route of Delivery Market Forecast by Region, 2022-2032(%)
Figure 76 Intranodal Route of Delivery Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
Figure 77 Global mRNA Intranodal Route of Delivery Market Forecast by Region, 2022-2032(%)
Figure 78 Global mRNA vaccines & therapeutics Market Forecast by End-Users 2022, 2027, 2032 (Revenue, CAGR %)
Figure 79 Global mRNA vaccines & therapeutics Market Forecast by End Users, 2022-2032 (US$ million, AGR %)
Figure 80 Global mRNA vaccines & therapeutics Market Share Forecast by End Users, 2022, 2032 (%)
Figure 81 Research Organizations Market Forecast by Region, 2022-2032 (US$ Mn )
Figure 82 Research Organizations Market Share Forecast, by Region, 2022-2032(%)
Figure 83 Hospitals & Clinics Market Forecast, by Region, 2022-2032 (US$ Mn )
Figure 84 Hospitals & Clinics Market Forecast, by Region, 2022-2032(%)
Figure 85 Global mRNA Vaccines & Therapeutics Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 86 Global mRNA Vaccines & Therapeutics Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 87 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 88 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 89 Global mRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 90 Global MRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 91 Global MRNA vaccines & therapeutics market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 92 North America mRNA Vaccines & Therapeutics Market Attractiveness Index
Figure 93 North America mRNA Vaccines & Therapeutics market by Region, 2022, 2027 & 2032 (US$ million)
Figure 94 North America mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 95 North America mRNA Vaccines & Therapeutics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 96 North America mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR %)
Figure 97 North America mRNA Vaccines & Therapeutics Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 98 North America mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR %)
Figure 99 North America mRNA Vaccines & Therapeutics Market Share Forecast by Vector Platform, 2022 & 2032 (%)
Figure 100 North America mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 101 North America mRNA Vaccines & Therapeutics Market Share Forecast by Vector Delivery Platform, 2022 & 2032 (%)
Figure 102 North America mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 103 North America mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Vector Delivery Platform, 2022 & 2032 (%)
Figure 104 North America mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 105 North America mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Non -Viral Vector Delivery Platform, 2022 & 2032 (%)
Figure 106 North America mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %)
Figure 107 North America mRNA Vaccines & Therapeutics Market Share Forecast by Applications, 2022 & 2032 (%)
Figure 108 North America mRNA vaccines & therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR %)
Figure 109 North America mRNA Vaccines & Therapeutics Market Share Forecast By Route of Delivery, 2022 & 2032 (%)
Figure 110 North America mRNA vaccines & therapeutics Market Forecast By End Users, 2022-2032 (US$ million, AGR %)
Figure 111 North America mRNA Vaccines & Therapeutics Market Share Forecast By End Users, 2022 & 2032 (%)
Figure 112 U.S. mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 113 Canada mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 114 Europe mRNA Vaccines & Therapeutics Market Attractiveness Index,2022
Figure 115 Europe mRNA Vaccines & Therapeutics Market by Country, 2022, 2027 & 2032 (US$ million)
Figure 116 Europe mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 117 Europe mRNA vaccines & therapeutics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 118 Europe mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR %)
Figure 119 Europe mRNA Vaccines & Therapeutics Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 120 Europe mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR %)
Figure 121 Europe mRNA Vaccines & Therapeutics Market Share Forecast by Vector Platform, 2022 & 2032 (%)
Figure 122 Europe mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 123 Europe mRNA Vaccines & Therapeutics Market Share Forecast by Vector Delivery Platform, 2022 & 2032 (%)
Figure 124 Europe mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 125 Europe mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Vector Delivery Platform, 2022 & 2032 (%)
Figure 126 Europe mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 127 Europe mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Non -Viral Vector Delivery Platform, 2022 & 2032 (%)
Figure 128 Europe mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %)
Figure 129 Europe mRNA Vaccines & Therapeutics Market Share Forecast by Applications, 2022 & 2032 (%)
Figure 130 Europe mRNA Vaccines & Therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR %)
Figure 131 Europe mRNA Vaccines & Therapeutics Market Share Forecast By Route of Delivery, 2022 & 2032 (%)
Figure 132 Europe mRNA Vaccines & Therapeutics Market Forecast by End Users-2032 (US$ million, AGR %)
Figure 133 Europe mRNA Vaccines & Therapeutics Market Share Forecast By End Users, 2022 & 2032 (%)
Figure 134 Germany mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 135 UK mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 136 France mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 137 Spain mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 138 Italy mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 139 Rest of Europe mRNA Vaccines & Therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 140 Asia Pacific mRNA vaccines and Therapeutics Market Attractiveness Index
Figure 141 Asia Pacific mRNA Vaccine & Therapeutics Market, by Region, 2022, 2027 & 2032 (US$ million)
Figure 142 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 143 Asia Pacific mRNA Vaccines & Therapeutics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 144 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR %)
Figure 145 Asia Pacific mRNA Vaccines & Therapeutics Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 146 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR %)
Figure 147 Asia Pacific mRNA Vaccines & Therapeutics Market Share Forecast by Vector Platform, 2022 & 2032 (%)
Figure 148 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 149 Asia Pacific mRNA Vaccines & Therapeutics Market Share Forecast by Vector Delivery Platform, 2022 & 2032 (%)
Figure 150 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 151 Asia Pacific mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Vector Delivery Platform, 2022 & 2032 (%)
Figure 152 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 153 Asia Pacific mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Non -Viral Vector Delivery Platform, 2022 & 2032 (%)
Figure 154 Asia Pacific mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %)
Figure 155 Asia Pacific mRNA Vaccines & Therapeutics Market Share Forecast by Applications, 2022 & 2032 (%)
Figure 156 Asia Pacific mRNA vaccines & therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR %)
Figure 157 Asia Pacific mRNA Vaccines & Therapeutics Market Share Forecast By Route of Delivery, 2022 & 2032 (%)
Figure 158 Asia Pacific mRNA vaccines & therapeutics market Forecast By End Users, 2022-2032 (US$ million, AGR %)
Figure 159 Asia Pacific mRNA Vaccines & Therapeutics Market Share Forecast By End Users, 2022 & 2032 (%)
Figure 160 China mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 161 India mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 162 Japan mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 163 South Korea mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 164 Australia mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 165 ROA mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 166 Latin America mRNA vaccines and Therapeutics Market Attractiveness Index
Figure 167 Latin America mRNA Vaccine & Therapeutics Market, by Region, 2022, 2027 & 2032 (US$ million)
Figure 168 Latin America mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 169 Latin America mRNA Vaccines & Therapeutics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 170 Latin America mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR %)
Figure 171 Latin America mRNA Vaccines & Therapeutics Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 172 Latin America mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR %)
Figure 173 Latin America mRNA Vaccines & Therapeutics Market Share Forecast by Vector Platform, 2022 & 2032 (%)
Figure 174 Latin America mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 175 Latin America mRNA Vaccines & Therapeutics Market Share Forecast by Vector Delivery Platform, 2022 & 2032 (%)
Figure 176 Latin America mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 177 Latin America mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Vector Delivery Platform, 2022 & 2032 (%)
Figure 178 Latin America mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 179 Latin America mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Non -Viral Vector Delivery Platform, 2022 & 2032 (%)
Figure 180 Latin America mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %)
Figure 181 Latin America mRNA Vaccines & Therapeutics Market Share Forecast by Applications, 2022 & 2032 (%)
Figure 182 Latin America mRNA vaccines & therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR %)
Figure 183 Latin America mRNA Vaccines & Therapeutics Market Share Forecast By Route of Delivery, 2022 & 2032 (%)
Figure 184 Latin America mRNA Vaccines & Therapeutics Market Forecast by End Users, 2032 (US$ million, AGR %)
Figure 185 Latin America mRNA Vaccines & Therapeutics Market Share Forecast By End Users, 2022 & 2032 (%)
Figure 186 Brazil mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 187 Argentina mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 188 Mexico mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 189 Rest of Latin America mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 190 Middle East & Africa mRNA vaccines and Therapeutics Market Attractiveness Index
Figure 191 Middle East & Africa mRNA Vaccine & Therapeutics Market, by Region, 2022, 2027 & 2032 (US$ million)
Figure 192 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 193 Middle East & Africa mRNA Vaccines & Therapeutics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 194 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Types, 2022-2032 (US$ million, AGR %)
Figure 195 Middle East & Africa mRNA Vaccines & Therapeutics Market Share Forecast by Therapeutics, 2022 & 2032 (%)
Figure 196 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Vector Platform, 2022-2032 (US$ million, AGR %)
Figure 197 Middle East & Africa mRNA Vaccines & Therapeutics Market Share Forecast by Vector Platform, 2022 & 2032 (%)
Figure 198 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 199 Middle East & Africa mRNA Vaccines & Therapeutics Market Share Forecast by Vector Delivery Platform, 2022 & 2032 (%)
Figure 200 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 201 Middle East & Africa mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Vector Delivery Platform, 2022 & 2032 (%)
Figure 202 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Carrier Mediated Non-Viral Vector Delivery Platform, 2022-2032 (US$ million, AGR %)
Figure 203 Middle East & Africa mRNA Vaccines & Therapeutics Market Share Forecast by Carrier Mediated Non -Viral Vector Delivery Platform, 2022 & 2032 (%)
Figure 204 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by Applications, 2022-2032 (US$ million, AGR %)
Figure 205 Middle East & Africa mRNA Vaccines & Therapeutics Market Share Forecast by Applications, 2022 & 2032 (%)
Figure 206 Middle East & Africa mRNA vaccines & therapeutics market Forecast By Route of Delivery, 2022-2032 (US$ million, AGR %)
Figure 207 Middle East & Africa mRNA Vaccines & Therapeutics Market Share Forecast By Route of Delivery, 2022 & 2032 (%)
Figure 208 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast by End Users, 2032 (US$ million, AGR %)
Figure 209 Middle East & Africa mRNA Vaccines & Therapeutics Market Share Forecast By End Users, 2022 & 2032 (%)
Figure 210 Saudi Arabia mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 211 UAE mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 212 Turkey mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 213 South Africa mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 214 Rest of Middle East mRNA vaccines & therapeutics market Forecast, 2022-2032 (US$ million, AGR %)
Figure 215 Global mRNA vaccines & therapeutics market: Company Share Analysis, 2021
Figure 216 AstraZeneca PLC: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 217 AstraZeneca P